The Blood Grouping Reagents Market in Latvia showed a gradual decrease from 2013 to 2023, with a noticeable dip in value per capita from $0.94 in 2013 to $0.86 in 2023. The consistent value of $0.87 from 2018 to 2022 indicates a period of stability before a slight decline in 2023. Year-on-year variation over 2022-2023 was close to -1.15%, while the compound annual growth rate (CAGR) over the last five years showed minimal variance, reflecting a stagnant market.
Future trends to watch for include possible technological advancements in blood grouping techniques and potential increases in healthcare funding, which could impact the market size positively. Continued monitoring of healthcare policies and innovative product launches will be crucial for understanding future market dynamics.
